Connect your AI

AptarGroup ATR Equity Method Income

Equity Method Income at other companies

West Pharmaceutical ServicesWST

$3.4M0.0%

AmcorAMCR

$0—

DuPont de Nemours, Inc.DD

-$1M+93.3%

IR

Ingersoll RandIR

$0+100%

Other financials

Income statement

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AptarGroup's equity method income?: AptarGroup (ATR) reported equity method income of $714K in Q1 2026.
How has AptarGroup's equity method income changed year-over-year?: AptarGroup's equity method income decreased by 65.8% year-over-year, from $2.09M to $714K.
What is the long-term trend for AptarGroup's equity method income?: Over 4 years (2021 to 2025), AptarGroup's equity method income has grown at a 80.8% compound annual growth rate (CAGR), from -$692K to $7.39M.
What does equity method income mean?: The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.